4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021178
CHIEF FINANCIAL OFFICER sold 18,889 shares at $32.89 ($621,259)
- CHIEF FINANCIAL OFFICER acquired 18,889 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-08-04 | Option exercise 10b5-1 | +18,889 | $22.89 | $432,369 | 45,898 | D: show line 1 in the form |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-08-04 | Sale 10b5-1 | −18,889 | $32.89 | $621,259 | 27,009 | D: show line 2 in the form |
| Open-market sales · 18,889 sh · avg $32.89 · $621,259 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-08-04 | Option exercise · Share Option 10b5-1 | −18,889 | 2,036 | D: show line 3 in the form |
Loading xslF345X05/form4-08062025_040802.xml…